EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Defining the Structure–Activity Relationships of Thiazolide Antivirals: Balancing Potency, Metabolic Stability, and Aqueous Solubility

Joshua Taujanskas, Sophie Pate, Andrew V Stachulski iD, Sara Piacentini, Simone La Frazia iD, M Gabriella Santoro, Paul M O'Neill iD

ChemMedChem · 2026-11-26 · 21 (22)

DOI: 10.1002/cmdc.70570 ↗

At a glance

Journal article in ChemMedChem, published online on 2026-11-13. Written by Joshua Taujanskas and 6 co-authors. Institution: Department of Chemistry, University of Liverpool, Liverpool, UK. Major MEDLINE topics: Antiviral Agents, Thiazoles. 37 references. The full text is freely available (open access, CC BY 4.0). Funded by: University of Liverpool.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Recent studies on thiazolide antivirals have identified compounds RM5038 and RM5021 as potent inhibitors of hepatitis B virus (HBV), hepatitis C virus (HCV), and influenza A, although their development has been limited by poor aqueous solubility and rapid metabolic clearance. In this work, a series of novel halogen‐substituted and 4′‐alkylsulfone thiazolide analogs were synthesized using updated convergent synthetic approaches and flexible protecting group strategies. DMPK evaluation demonstrated that 3‐X halogen substitution significantly improved aqueous solubility in parallel to enhancing metabolic stability. Within the chlorothiazolide series, compounds 10g and 10l displayed much improved metabolic stability profiles, excellent aqueous solubility representing a 10‐fold improvement over the parent drug, together with low single‐digit micromolar antiviral (influenza A) activity and acceptable in vitro safety indices. Evaluation of the 4′‐alkylsulfone thiazolides also revealed improved in vitro DMPK profiles while retaining micromolar antiviral potency. SAR analysis indicated that short alkyl sulfone substituents containing two to three carbons are optimal for antiviral activity, while branched alkyl groups may provide additional metabolic advantages. In summary, compounds 10g, 10l, and 15d represent promising early leads for progression to in vivo profiling and additional preclinical evaluation.

Subjects

MeSH terms (MEDLINE)

Antiviral AgentsThiazolesStructure-Activity RelationshipSolubilityAnimalsHumansHepacivirusHepatitis B virusMolecular StructureWaterInfluenza A virusMicrobial Sensitivity TestsDose-Response Relationship, DrugDogs

Author keywords

DMPK optimizationinfluenza Amedicinal chemistrynitazoxaniderespiratory virusthiazolide antivirals

Substances

Antiviral AgentsThiazolesWater

Authors and institutions

  • Department of Chemistry, University of Liverpool, Liverpool, UK.
  • Department of Biology, University of Rome Tor Vergata, Rome, Italy.
  • Institute of Translational Pharmacology, CNR, Rome, Italy.

ORCID profiles: Andrew V Stachulski, Simone La Frazia, Paul M O'Neill

Funding

  • University of Liverpool

Cite

APA

Taujanskas, J., Pate, S., Stachulski, A. V., Piacentini, S., La Frazia, S., Santoro, M. G., & O'Neill, P. M. (2026). Defining the Structure–Activity Relationships of Thiazolide Antivirals: Balancing Potency, Metabolic Stability, and Aqueous Solubility. ChemMedChem, 21(22). https://doi.org/10.1002/cmdc.70570

Vancouver

Taujanskas J, Pate S, Stachulski AV, Piacentini S, La Frazia S, Santoro MG, et al. Defining the Structure–Activity Relationships of Thiazolide Antivirals: Balancing Potency, Metabolic Stability, and Aqueous Solubility. ChemMedChem. 2026;21(22). doi:10.1002/cmdc.70570

BibTeX
@article{Taujanskas2026,
  author = {Taujanskas, Joshua and Pate, Sophie and Stachulski, Andrew V and Piacentini, Sara and La Frazia, Simone and Santoro, M Gabriella and O'Neill, Paul M},
  title = {Defining the Structure–Activity Relationships of Thiazolide Antivirals: Balancing Potency, Metabolic Stability, and Aqueous Solubility},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {22},
  doi = {10.1002/cmdc.70570}
}
Start for free →